SNY FY 2011 Earnings Report — Sanofi Revenue & Financial Results | Market Cap Arena

FY 2011 Earnings

Reported December 30, 2011

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2011	Prior Q	FY 2010	QoQ Change	YoY Change
Revenue	$41.1B	—	$39.9B	—	3.0%
Op. Income	$6.9B	—	$7.7B	—	-10.3%
Gross Margin	69.0%	—	72.4%	—	-3.4pp
Net Margin	16.1%	—	16.1%	—	0.0pp
EPS (Diluted)	$2.52	—	$2.46	—	2.4%
Free Cash Flow	$8.8B	—	$9.6B	—	-7.9%

Revenue Flow

Item	Amount
REVENUE	$41.1B
Cost of Revenue	$12.7B
GROSS PROFIT	$28.3B
R&D Expenses	$5.6B
Selling & Marketing	$10.0B
General & Administrative	$0
SG&A Expenses	$10.0B
Other Expenses	$5.9B
Operating Expenses	$21.5B
Cost & Expenses	$34.2B
OPERATING INCOME	$6.9B
Interest Income	$125M
Interest Expense	$589M
Other Income/Expenses	$546M
INCOME BEFORE TAX	$7.4B
Income Tax Expense	$515M
Net Income from Continuing Ops	$6.9B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$6.6B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$6.6B
D&A	$6.5B
EBIT	$7.0B
EBITDA	$13.5B
EPS	$3
EPS Diluted	$3

Income Statement

Item	Amount
REVENUE	$41.1B
Cost of Revenue	$12.7B
GROSS PROFIT	$28.3B
R&D Expenses	$5.6B
Selling & Marketing	$10.0B
General & Administrative	$0
SG&A Expenses	$10.0B
Other Expenses	$5.9B
Operating Expenses	$21.5B
Cost & Expenses	$34.2B
OPERATING INCOME	$6.9B
Interest Income	$125M
Interest Expense	$589M
Other Income/Expenses	$546M
INCOME BEFORE TAX	$7.4B
Income Tax Expense	$515M
Net Income from Continuing Ops	$6.9B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$6.6B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$6.6B
D&A	$6.5B
EBIT	$7.0B
EBITDA	$13.5B
EPS	$3
EPS Diluted	$3

Cash Flow Statement

Item	Amount
Net Income	$6.7B
Depreciation & Amortization	$6.5B
Stock-Based Compensation	$0
Deferred Income Tax	-$2.2B
Other Non-Cash Items	$530M
Change in Working Capital	-$603M
OPERATING CASH FLOW	$10.9B
Capital Expenditure	-$2.1B
Acquisitions (Net)	-$15.9B
Purchases of Investments	-$30M
Sales/Maturities of Investments	$0
Other Investing Activities	$816M
NET CASH FROM INVESTING	-$17.2B
Net Debt Issuance	$6.2B
Common Stock Repurchased	-$1.3B
Common Dividends Paid	-$1.6B
Other Financing Activities	-$20M
NET CASH FROM FINANCING	$3.4B
FREE CASH FLOW	$8.8B
Net Change in Cash	-$2.7B

Balance Sheet

Item	Amount
Cash & Equivalents	$2.3B
Short-Term Investments	$203M
Net Receivables	$11.9B
Inventory	$7.1B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$24.3B
PP&E (Net)	$12.6B
Goodwill	$45.2B
Intangible Assets	$27.7B
Long-Term Investments	$3.7B
Tax Assets	$4.3B
Other Non-Current Assets	$85M
TOTAL NON-CURRENT ASSETS	$93.5B
TOTAL ASSETS	$117.9B
Account Payables	$3.7B
Short-Term Debt	$3.4B
Deferred Revenue	$0
Other Current Liabilities	$5.2B
TOTAL CURRENT LIABILITIES	$15.9B
Long-Term Debt	$14.5B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$7.6B
Other Non-Current Liabilities	$13.7B
TOTAL NON-CURRENT LIABILITIES	$36.0B
TOTAL LIABILITIES	$51.9B
Common Stock	$3.1B
Additional Paid-In Capital	$0
Retained Earnings	$62.6B
Treasury Stock	-$1.1B
Accum. Other Comp. Income	$1.2B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$65.8B
Minority Interest	$199M
TOTAL EQUITY	$66.0B
TOTAL LIABILITIES & EQUITY	$117.9B
Total Debt	$18.1B
Net Debt	$15.8B